:max_bytes(150000):strip_icc()/VW-Health-Ozembic-Injection-site-V2-f0e98eb1833f48e898d8a19800fb515f.jpg)
Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Diabetes Metab Syndrome Obes Targets Ther (2021) 14:295572
Tibullo D, Li Volti G, Giallongo C, Grasso S, Tomassoni D, Anfuso CD, et al
Clinical evidence SELECT cardiovascular outcomes SELECT enrolled 17,604 adults aged 45 years with established atherosclerotic cardiovascular disease (prior MI, stroke, or symptomatic peripheral arterial disease) and BMI 27 kg/m, but without diabetes, randomizing them 1:1 to semaglutide 2.4 mg SC weekly (after titration) or placebo on top of standard CV therapies
doi: 10.1016/j.jff.2022.105042 127 SinghRDhaleMSKishoreA
doi: 10.1111/j.1749-6632.1994.tb44124.x 39 CiprianiG.GibbonsS
US$ 21.34
US$ 26.83
US$ 20.74
